Jae-Won Shim

Jae-Won Shim is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of stem cell biology. With a total of 4 patents, he has made remarkable strides in the differentiation of pluripotent and multipotent stem cells, particularly in relation to dopamine neurons.

Latest Patents

One of his latest patents focuses on midbrain dopamine (DA) neurons for engraftment. This invention relates to the lineage-specific differentiation of pluripotent or multipotent stem cells, including human embryonic stem cells (hESC) and nonembryonic human induced pluripotent stem cells (hiPSC). The methods described in this patent aim to direct the differentiation of hESC and/or hiPSC into floor plate midbrain progenitor cells, which can then be developed into large populations of midbrain fate FOXA2LMX1ATH dopamine (DA) neurons. These neurons are intended for various applications, including in vitro drug discovery assays, neurology research, and therapeutic uses to address diseases related to dopamine neuron deficiencies, such as Parkinson's disease.

Career Highlights

Jae-Won Shim is currently affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance his research in stem cell biology. His work has been instrumental in developing methods that enhance the understanding and treatment of neurological disorders.

Collaborations

He has collaborated with notable colleagues in the field, including Lorenz Studer and Sonja Kriks, further enriching his research endeavors and contributions to science.

Conclusion

Jae-Won Shim's innovative work in stem cell biology, particularly in the differentiation of dopamine neurons, showcases his commitment to advancing medical research and therapeutic applications. His contributions are paving the way for future breakthroughs in treating neurological diseases.

Profile summary based on public USPTO records.